Compare Revolution Medicines Inc. Common Stock (RVMD) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revolution Medicines Inc. Common Stock vs iShares Silver Trust — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while iShares Silver Trust trades at $54.91 (market cap $29.02B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and iShares Silver Trust for 89 Days on average.
| RVMD | SLV | |
|---|---|---|
Market Cap | $40.32B | $29.02B |
Volume | 4,855,734 | 16,510,334 |
Sector | Health | — |
52-Week High | $221.15 | $105.57 |
52-Week Low | $47.50 | $42.40 |
Typical Hold Time | 0 Days | 89 Days |
Enterprise Value | $37.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SLV trades at $54.78, up 1.78% today, but faces a bearish technical outlook with 18 sell signals versus 4 buy signals. The company reported $2.17M net income for 2024 despite zero revenue, with total assets surging to $13.41B from $10M in 2023. Recent news highlights silver's volatility amid Fed policy uncertainty and rising Treasury yields.
Outlook remains cautious given technical weakness and macroeconomic pressures on precious metals. The asset growth without corresponding revenue generation raises fundamental concerns, while institutional sentiment appears mixed amid silver's recent price decline of nearly 50% from recent highs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
